A Study of Neoadjuvant TCHpy（Pyrotinib ，Trastuzumab，Carboplatin and Paclitaxel）for ER+/HER2+ Breast Cancer
Clinical trial NCT06000917 · RECRUITING
Trial details
- NCT number
- NCT06000917
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-11
- Primary completion
- 2025-05-11
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.